Improving the diagnosis of severe malaria in African children using platelet counts and plasma PfHRP2 concentrations
James A Watson1,2, Sophie Uyoga3, Perpetual Wanjiku3
1Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Insights
Diagnosing severe malaria in children is challenging. A combination of low platelet count and high Plasmodium falciparum histidine-rich protein 2 (PfHRP2) levels aids in accurate diagnosis, though other severe illnesses can be misidentified.
Area of Science:
- Tropical Medicine
- Infectious Diseases
- Biostatistics
Background:
- Accurate diagnosis of severe malaria caused by Plasmodium falciparum in children in high-transmission areas remains a significant clinical challenge.
- Existing diagnostic methods may lack sufficient sensitivity or specificity in pediatric populations.
Purpose of the Study:
- To evaluate the diagnostic accuracy of a combined marker approach for severe falciparum malaria in children.
- To identify key differentiating factors between severe malaria and other causes of severe illness in pediatric patients.
Main Methods:
- Bayesian latent class models were fitted using data from 2649 pediatric and adult patients across three countries.
- Diagnostic markers analyzed included platelet count and plasma P. falciparum histidine-rich protein 2 (PfHRP2) concentration.
- Comparison of clinical features between confirmed severe malaria cases and misdiagnosed children.
Main Results:
- A combination of platelet count ≤150,000/microl and plasma PfHRP2 ≥1000 ng/ml showed 74% sensitivity and 93% specificity for severe falciparum malaria.
- Pediatric patients with true severe malaria exhibited higher parasite densities and lower hematocrits compared to misdiagnosed children.
- An estimated one-third of children in African clinical studies for severe malaria had alternative underlying causes for their illness.
Conclusions:
- The combined diagnostic marker approach offers improved accuracy for severe falciparum malaria in children in resource-limited settings.
- Distinguishing severe malaria from other severe febrile illnesses is crucial, as a significant proportion of pediatric cases may be misattributed.
- Further research is needed to refine diagnostic strategies and improve patient outcomes in high-transmission areas.
Abstract:
Severe malaria caused by Plasmodium falciparum is difficult to diagnose accurately in children in high-transmission settings. Using data from 2649 pediatric and adult patients enrolled in four studies of severe illness in three countries (Bangladesh, Kenya, and Uganda), we fitted Bayesian latent class models using two diagnostic markers: the platelet count and the plasma concentration of P. falciparum histidine-rich protein 2 (PfHRP2). In severely ill patients with clinical features consistent with severe malaria, the combination of a platelet count of ≤150,000/microl and a plasma PfHRP2 concentration of ≥1000 ng/ml had an estimated sensitivity of 74% and specificity of 93% in identifying severe falciparum malaria. Compared with misdiagnosed children, pediatric patients with true severe malaria had higher parasite densities, lower hematocrits, lower rates of invasive bacterial disease, and a lower prevalence of both sickle cell trait and sickle cell anemia. We estimate that one-third of the children enrolled into clinical studies of severe malaria in high-transmission settings in Africa had another cause of their severe illness.
